Category Archives: (Midwest Communications, Inc. Syndication Interface) Business News (Master Feed)

LONDON, Feb 23 (Reuters) - High U.S. import tariffs appear to be here to stay and their full impact represent a meaningful change which is likely to take "many years" to be felt, Bank of England polic...

By Doina Chiacu, Susan Heavey and David Lawder WASHINGTON, Feb 23 (Reuters) - U.S. President Donald Trump on Monday warned countries against backing away from recently negotiated trade deals with the ...

Feb 23 (Reuters) - The U.S. Commerce Department on Monday will reveal a preliminary decision on whether to impose anti-subsidy duties on solar cells and panels imported from India, Laos and Indonesia....

By Mike Dolan Feb 23 - What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets It's fair to say financial markets are just as confused about U.S. trade policy...

Feb 23 (Reuters) - Novo Nordisk shares slumped by more than 16% on Monday, wiping away the remaining gains brought by its blockbuster weight-loss drug Wegovy, after the drugmaker said its next-generat...

By Padmanabhan Ananthan Feb 23 (Reuters) - Merck said on Monday it would create a separate division for its cancer business, anchored by its top-selling drug Keytruda, as the U.S. drugmaker braces for...

ZURICH, Feb 23 (Reuters) - Switzerland still plans to broker a legally-binding agreement from talks with the United States aimed at finalising a preliminary deal struck in late 2025 that cut U.S. tari...

By Anuja Bharat Mistry and Krisha Bhatt Feb 23 (Reuters) - Domino's Pizza beat Wall Street estimates for fourth-quarter U.S. same-store sales on Monday, as value-driven promotions and new menu items f...

By Nora Eckert and Abhirup Roy Feb 23 (Reuters) - Automakers are racing toward a key milestone on the long road to fully driverless cars: systems that let drivers take their eyes off the road - to sho...

Feb 23 (Reuters) - Gilead Sciences said on Monday it will buy cancer therapy partner Arcellx for an implied equity value of $7.8 billion, expanding their cell therapy development collaboration that st...